BiotechTube
Mosaic Biosciences

Mosaic Biosciences

Boulder, United States· Est.
mosaicbio.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Mosaic Biosciences is a privately held, US-based biologics discovery CRO founded in 2016. It provides end-to-end integrated services to external partners, leveraging a function-first screening strategy, early developability assessment, and access to proprietary FHC technology. The company's leadership team comprises industry veterans with proven track records in advancing clinical candidates and building platforms at major biopharma firms. Mosaic operates as a fee-for-service partner, enabling client programs rather than developing its own proprietary therapeutic pipeline.

Immunology

Technology Platform

Integrated biologics discovery platform combining antibody libraries, protein engineering, function-first screening, and early developability assessment. Includes access to proprietary FHC technology and a comprehensive suite of protein science and analytical tools (SPR, BLI, HPLC, MS).

Opportunities

The growing dominance of biologics in the pharmaceutical pipeline and the biotech industry's reliance on outsourcing for specialized, capital-efficient R&D create a large and expanding market for integrated discovery services.
Mosaic's focus on complex proteins and early developability addresses a key industry need to reduce late-stage attrition, positioning it as a high-value partner.

Risk Factors

Revenue is highly susceptible to downturns in biotech funding cycles.
The company faces intense competition from large global CROs and specialized platform firms.
As a service provider, it retains no therapeutic IP, capping potential upside from successful drug programs it enables.

Competitive Landscape

Mosaic competes in the biologics discovery CRO segment against large, diversified players like LabCorp and IQVIA, specialized discovery platforms like AbCellera and Twist Bioscience, and numerous boutique labs. Its differentiation hinges on integrated, end-to-end services, a function-first strategy, and a leadership team with deep industry R&D experience.

More companies in Biologics / Biosimilars →More companies in United States →